Cargando…
Immunomodulator comedication promotes the reversal of anti-drug antibody-mediated loss of response to anti-TNF therapy in inflammatory bowel disease
PURPOSE: Loss of therapeutic response (LOR) due to anti-drug antibodies (ADA) against tumor necrosis factor (TNF) inhibitors is common in patients with inflammatory bowel disease (IBD). We aimed to investigate whether immunomodulator comedication can reverse the immunogenic LOR to TNF inhibitors in...
Autores principales: | Stallhofer, Johannes, Guse, Jan, Kesselmeier, Miriam, Grunert, Philip Christian, Lange, Kathleen, Stalmann, Robert, Eckardt, Verena, Stallmach, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968255/ https://www.ncbi.nlm.nih.gov/pubmed/36840779 http://dx.doi.org/10.1007/s00384-023-04349-1 |
Ejemplares similares
-
The Political Force of the Comedic
por: Webber, Julie, et al.
Publicado: (2020) -
Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-α
por: Park, Jihye, et al.
Publicado: (2022) -
Fäkaler Mikrobiomtransfer – Indikationen, Risiken und Chancen
por: Stallmach, Andreas, et al.
Publicado: (2022) -
Effects of anti-TNF therapy and immunomodulators on anxiety and
depressive symptoms in patients with inflammatory bowel disease: a 5-year
analysis
por: Siebenhüner, Alexander R., et al.
Publicado: (2021) -
Effect of antiepileptic drug comedication on lamotrigine concentrations
por: Lovrić, Mila, et al.
Publicado: (2018)